Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07225491 · ClinicalTrials.gov registry record
Spine Oncology Registry
A clinical trial of Spine Metastases and Spine Tumor, sponsored by Ohio State University Comprehensive Cancer Center.
- Recruiting
- Registry status
- 3,000
- Enrollment target
- 3
- Study locations
NCT07225491: Recruiting study of Spine Metastases and Spine Tumor, sponsored by Ohio State University Comprehensive Cancer Center.
NCT07225491 is a study of Spine Metastases and Spine Tumor that is actively recruiting participants, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 3,000 participants, above the 64-participant average among 7 other Spine Metastases trials with a reported enrollment target (4588% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07225491, a study of Spine Metastases and Spine Tumor, is actively recruiting participants, sponsored by Ohio State University Comprehensive Cancer Center.
- RECRUITING
- Registry status
- 3,000 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is an observational study to evaluate hardware related and oncologic outcomes in adult patients with primary and metastatic spine disease undergoing separation surgery followed by radiation treatment.
Conditions Studied
Study Locations (3)
Michigan
- University of Michigan - Ann Arbor
New Jersey
- Rutgers Robert wood Johnson Medical School - New Brunswick
Ohio
- The Ohio State University Wexner Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2025-11-24 |
| Est. Completion | 2037-12-31 |
What NCT07225491 shows while recruiting
NCT07225491 is an observational study that tracks outcomes without assigning an intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus, above the 64-participant average among 7 other Spine Metastases trials with a reported enrollment target (4588% higher).
The record links to 3 conditions, with Spine Metastases appearing as the primary indexed condition, and to 0 interventions.
NCT07225491 reports a single indexed study location in Michigan, New Jersey, Ohio.
Frequently Asked Questions
What is clinical trial NCT07225491 about?
NCT07225491 is a clinical study titled "Spine Oncology Registry". This is an observational study to evaluate hardware related and oncologic outcomes in adult patients with primary and metastatic spine disease undergoing separation surgery followed by radiation treatment.
What is the current status of trial NCT07225491?
This trial is currently recruiting. The enrollment target is 3,000 participants. The study started on 2025-11-24. Estimated completion is 2037-12-31.
What conditions does trial NCT07225491 study?
This clinical trial studies the following conditions: Spine Metastases, Spine Tumor, Spine Cancer.
Who is sponsoring clinical trial NCT07225491?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07225491 being conducted?
This trial has 3 study locations across Michigan, New Jersey, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spine Metastases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Prophylactic Radiotherapy of MInimally Symptomatic Spinal Disease
RECRUITING · Phase 1
-
Laser Interstitial Thermal Ablation and Stereotactic Radiosurgery for Patients With Spine Metastases
RECRUITING · NA
-
Single- vs. Two-Fraction Spine Stereotactic Radiosurgery for the Treatment of Vertebral Metastases
RECRUITING · Phase 2
-
Dose-Escalated Spine SbRT for Localized Metastasis to the Spinal Column
RECRUITING · NA
-
Definitive Radiation for High-Risk Spine Metastases
RECRUITING · Phase 2
-
Radiofrequency Ablation/Bone Augmentation + Radiotherapy vs Radiotherapy Alone
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI